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Abstract
Malaria in pregnancy (MiP) induces intrauterine growth restriction (IUGR) and pre-
term labour (PTL). However, its effects on yolk sac morphology and function are 
largely unexplored. We hypothesized that MiP modifies yolk sac morphology and 
efflux transport potential by modulating ABC efflux transporters. C57BL/6 mice in-
jected with Plasmodium berghei ANKA (5 × 105 infected erythrocytes) at gestational 
day (GD) 13.5 were subjected to yolk sac membrane harvesting at GD 18.5 for his-
tology, qPCR and immunohistochemistry. MiP did not alter the volumetric propor-
tion of the yolk sac's histological components. However, it increased levels of Abcb1a 
mRNA (encoding P-glycoprotein) and macrophage migration inhibitory factor (Mif 
chemokine), while decreasing Abcg1 (P < 0.05); without altering Abca1, Abcb1b, Abcg2, 
Snat1, Snat2, interleukin (Il)-1β and C-C Motif chemokine ligand 2 (Ccl2). Transcripts 
of Il-6, chemokine (C-X-C motif) ligand 1 (Cxcl1), Glut1 and Snat4 were not detectible. 
ABCA1, ABCG1, breast cancer resistance protein (BCRP) and P-gp were primarily 
immunolocalized to the cell membranes and cytoplasm of endodermic epithelium 
but also in the mesothelium and in the endothelium of mesodermic blood vessels. 
Intensity of P-gp labelling was stronger in both endodermic epithelium and meso-
thelium, whereas ABCA1 labelling increased in the endothelium of the mesodermic 
blood vessels. The presence of ABC transporters in the yolk sac wall suggests that 
this fetal membrane acts as an important protective gestational barrier. Changes in 
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1  | INTRODUC TION
The harmful effects of malaria in pregnancy (MiP) include high rates 
of maternal anaemia and death, as well as spontaneous abortion, 
fetal intrauterine growth restriction (IUGR), preterm labour (PTL), 
low birthweight, foetal/neonatal demise and impaired postnatal 
cognitive and neurosensory development.1-3 MiP is characterized by 
adherence of plasmodium falciparum-infected erythrocytes to spe-
cific syncytiotrophoblast glycosaminoglycans, a condition referred 
to as “placental malaria”.3,4 In response, the placental barrier may 
undergo various adaptive changes that comprise activation and mi-
gration of immune cells, alteration of cytokine and chemokine out-
put,2,5 intervillositis, decreased enrichment of syncytiotrophoblast 
microvilli and lower expression of placental glucose (GLUT1), amino 
acid (SNAT1, SNAT2, Cat1, Lat1 and 4F2hc), solute carrier (SLC) drug 
uptake (Oatp2b1, Oct3, Ent1 and Ent2) and nutrient/drug efflux ABC 
transport systems (ABCA1, BCRP and P-gp).6-11
The ATP-binding cassette (ABC) transport system is highly ex-
pressed in different trophoblastic lineages.12-14 Its disruption has 
been associated with IUGR, PTL, preeclampsia and chorioamnioni-
tis.13,15-17 In this context, reports from different groups have demon-
strated that it participates in the adaptive trophoblastic responses to 
maternal infection.9,12,14,16-18 Comprised of 50 transporters divided 
into seven sub-classes ranging from ABCA through ABCG,19 these 
transmembrane transporters are expressed in different cell types, 
including those from biological barriers.12 They are responsible for 
the efflux of diverse endogenous and exogenous substrates, from 
one side to the other of the plasma membrane.20 There are a mul-
titude of endogenous substrates including lipids, phospholipids, 
cytotoxic oxysterols, amino acids, steroid hormones, folate, metab-
olites and pro-inflammatory cytokines and chemokines. Exogenous 
substrates comprise environmental toxins (bisphenol A, ivermectin, 
pesticides) and clinically relevant drugs (antibiotics, antiretrovirals, 
antidepressants and synthetic glucocorticoids). ABC transporters 
are major components of the immune response and mediate nutrient 
transfer and fetal protection against drugs and environmental toxins 
that may be circulating in the maternal blood.12,20,21
The lipid transporters, ABCA1 and ABCG1 (encoded by the ABCA1 
and ABCG1 genes, respectively), and the multidrug resistance trans-
porters, P-glycoprotein (P-gp/ABCB1) and breast cancer-related pro-
tein (BCRP/ABCG2) are amongst the best-described ABC transporters 
in the syncytial barrier. ABCA1, P-gp and BCRP are predominantly 
expressed in the apical membrane of the syncytiotrophoblast, and 
efflux their substrates from the fetal side into the maternal circulation, 
whereas ABCG1 is localized in the syncytiotrophoblast's basolateral 
membrane and efflux cholesterol into the fetal circulation.12
Plasmodium berghei ANKA (PBA) infection is largely used to 
mimic malaria infection in mice. In pregnant BALB/c mice, PBA de-
creases placental Abca1, Abcb1a and Abcb1b (both encoding P-gp 
in rodents) and Abcg2.11 Similarly, in pregnant C57BL/6 dams, 
PBA leads to IUGR, PTL and impairs the placental expression of 
ABCA1/Abca1, P-gp/Abcb1b and BCRP/Abcg2,9 suggesting that MiP 
has the potential to increase fetal exposure to a range of clinically 
relevant substrates capable of profoundly impacting fetal outcome, 
via dysfunction of ABC transporters in the placental barrier.
The human yolk sac is the major hematopoietic site22 and is 
the source of primordial germ cells in early pregnancy.23 It is esti-
mated that human yolk sac is viable until the 49th day of gestation.24 
Emerging evidence suggests the yolk sac is an important nutrient 
exchange site between the coelomic fluid and the fetal capillaries 
present in its mid-mesodermal layer; or alternatively, it delivers 
nutrients to the embryo primitive gut via the vitelline duct.24-26 In 
mice, the visceral portion of the yolk sac involves the embryo amni-
otic membrane and is functional throughout pregnancy, mediating 
the transport of critical substances from the mother to the fetus, 
acting as a syncytiotrophoblast equivalent throughout intrauterine 
development.27,28 It is known that human24 and mouse24,29 yolk sac 
express different ABC transport carriers, suggesting that this mem-
brane acts together with the placenta and other fetal membranes to 
form an efficient protective barrier during gestation.
Despite the importance of the yolk sac for embryo and fetal devel-
opment, no studies have investigated the effects of MiP on yolk sac 
morphology and efflux transport expression. In the present study, we 
hypothesized that MiP, in a murine model of malaria-induced IUGR and 
PTL, modifies the yolk sac morphology and efflux transport potential, 
via modulation of key ABC efflux transporters. Improved knowledge as 
to how the yolk sac responds to MiP may improve the understanding of 
the mechanisms by which malaria impacts pregnancy outcome.
2  | MATERIAL AND METHODS
2.1 | Animals
An animal model of severe experimental malaria, which recapitulates 
many of the features of the human malarial disease in pregnancy, 
ABCA1 and P-gp in MiP may alter the biodistribution of toxic substances, xenobiotics, 
nutrients and immunological factors within the fetal compartment and participate in 
the pathogenesis of malaria-induced IUGR and PTL.
K E Y W O R D S
ABCA1, ABCG1, Breast Cancer Resistance Protein (BCRP), malaria in pregnancy (MiP), 
P-glycoprotein (P-gp), Plasmodium berghei ANKA, yolk sac
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including placental malarial, IUGR, low birthweight and PTL, was used 
as previously described.9 This model resulted in a 20% rate of PTL in 
infected dams; however, all analyses were undertaken in the yolk sac 
of fetuses born at GD18.5 (ie term). Briefly, C57BL/6 female mice (8 
to 10 weeks old) were housed at room temperature (22°C), with a 
light cycle of 12-hours light/12-hours dark and were mated. Animals 
were maintained on a commercial Nuvilab® CR1 (Nuvilab, PR, Brazil) 
chow and water ad libitum. Mating was confirmed by the presence of 
a vaginal plug and was defined as gestational day (GD) 0.5. Pregnant 
dams were injected intraperitoneally (ip) with 5 × 105 erythrocytes 
infected with Plasmodium berghei ANKA (PBA group) or with saline 
(control group) at GD13.5. Killing was performed at GD18.5, using a 
pentobarbital overdose (300 mg/kg ip), followed by maternal and fetal 
decapitation. Six PBA-infected dams from our previous cohort,9 which 
exhibited peripheral parasitaemia (approximately 16% of infected 
erythrocytes) at GD18.5, were included in this study. Approval was ob-
tained from the Institutional ethics committee (CEUA-190/13), regis-
tered within the Brazilian National Council for Animal Experimentation 
Control (protocol number 01200.001568/2013-8). All procedures fol-
lowed the “Principles of Laboratory Animal Care” formulated by the 
National Society for Medical Research and the US National Academy 
of Sciences Guide for the Care and Use of Laboratory Animals.
2.2 | Volumetric proportion assessment of mouse 
visceral yolk sac
The visceral yolk sac of PBA-infected and control animals (n = 6/group) 
was dissected and immediately immersed in buffered 4% paraform-
aldehyde phosphate solution (24 hours). After fixation, samples were 
dehydrated in an ethanol series, diaphanized in xylene and embedded 
in paraffin wax (Histopar, SP, Brazil). Sections (4 μm) were stained with 
haematoxylin and eosin (H&E). Image acquisition and analysis were 
performed on a Zeiss Axiolab 1 photomicroscope, coupled with a CCD 
camera and computer running Zeiss AxioVision (Carl Zeiss, NY, EUA). 
The histomorphological analysis was undertaken using the Fiji ImageJ 
1.0 program (ImageJ, WI, USA). Estimation of relative volume of the dif-
ferent components of the yolk sac (endodermic epithelium, mesoder-
mal connective tissue, mesodermal blood vessels and mesothelium) was 
undertaken by superimposing yolk sac histological photomicrographs 
with a grid of equidistant points (measuring 25 μm distance between 
two points). 1000 points coinciding with each of the histological compo-
nents evaluated were recorded, yielding a variable number of histologi-
cal sections evaluated per dam, which corresponded to a total average 
area of 455 mm2 per dam. The volumetric proportion (VP) of each histo-
logical component was calculated as VP = NP ×100/1000, where NP = 
number of equivalent points on each histological component.30
2.3 | qPCR
Samples of the visceral yolk sac (n = 6/group) were immersed in RNA 
Later solution (Invitrogen, MA, USA) and frozen at −20°C until further 
processing. Extraction of total RNA was undertaken using TRIzol 
(Invitrogen) with homogenization conducted using a TissueLyser 
LT (Qiagen, Hilden, Germany). Concentration and purity of samples 
were determined by spectrophotometric analysis (Implen nanopho-
tometer, Munich, Germany). Total RNA (1 μg) was reverse-transcribed 
into cDNA, using the High Capacity cDNA Reverse Transcription kit 
(Applied Byosystems, CA, USA), according to the manufacturer's 
instructions. cDNA (4 μL) was added to the primer-containing mix 
(intron-exon spanning) of each gene of interest (Table 1), as well as 
with the fluorescent DNA interlayer Eva Green (Biotium, CA, USA), 
in a total volume of 6 μL. The quantification of each gene of interest 
relative to the reference genes, Ywhaz, Ppib and Gapdh (table 1), was 
performed in the QuantStudio Real-Time PCR (Applied Biosystems, 
CA, USA), with the following amplification cycles: initial denatura-
tion at 50°C for 2 minutes and then at 95°C for 10 minutes, followed 
by 40 cycles of denaturation at 95°C for 15 seconds. Annealing was 
performed at 60°C for 30 seconds and extension at 72°C for 45 sec-
onds. Differences in mRNA gene expression were calculated accord-
ing to the 2−ΔΔCT method,31 and the assay was considered acceptable 
when its efficiency ranged from 95% to 105%.
2.4 | Immunohistochemistry
Yolk sac sections (7 μm, n = 6/group) were dewaxed and rehydrated. 
Term mouse placental sections were processed simultaneously, 
as positive controls. Endogenous peroxidase activity was blocked 
using the Hydrogen Peroxide Block Kit (Springer, Berlin, Germany). 
Antigen retrieval was performed by heating the sections in Tris-
EDTA buffer pH 9, followed by microwave heating in citrate buffer 
(0.1 mol/L, pH 6) allowing to cool on ice (10 minutes). Blocking was 
performed by incubation with skimmed milk 10% in PBS (30 min-
utes), followed by Protein Block Kit (Springer; 30 minutes). Sections 
were then incubated overnight with anti–P-gp (mouse monoclonal; 
Santa Cruz Biotechnology, EUA; 1:500), anti-ABCA1 (mouse mono-
clonal; Abcam, EUA; 1:100), anti-BCRP (mouse monoclonal; Merck 
Millipore, GER; 1:200) and anti-ABCG1 (rabbit polyclonal; Thermo 
Fisher Scientific, EUA; 1:100) antibodies. Visualization of protein 
was performed using the Springer Kit following the manufacturer's 
instructions. Sections were stained with haematoxylin. Omission of 
the primary antibody provided negative controls.
Evaluation of the area and intensity of the immunolabelled yolk 
sac components (endodermal epithelium, connective tissue, endo-
thelium and mesothelium) was performed using a semi-quantitative 
scoring described previously, with modifications.16,32 For the im-
munolabelled area, the scores were as follows: 0) undetectable; 1) 
1%-25%; 2) 26%-50%; 3) 51%-75%; and 4) 76%-100%. For intensity 
immunolabelling, graded scores were as follows: 0) no detectable 
staining; 1) weak; 2) moderate; 3) strong; and 4) very strong inten-
sity. At least 5 fields were evaluated (20 × magnification) for each 
dam. Two operators blinded to the experimental groups performed 
independent evaluation. An average of the scores for both evalua-
tions was calculated.
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2.5 | Statistical method
Values are expressed as mean ± standard error of the mean (SEM) 
and were analysed using PRISM program (GraphPad Software Inc, 
CA, USA). Statistical assessment of volumetric dimensions, qPCR 
and immunohistochemistry data was undertaken in the yolk sac of 
fetuses exhibiting the closest placental weight to the mean weight 
of all placentae from each litter. Thus, “n” represents the number of 
litters.9,33,34 After confirming the non-parametric distribution of the 
data and exclusion of outliers (Grubbs' test), differences between 
PBA-infected and control groups were assessed by non-parametric 
Mann-Whitney test, when comparing two variables, and by Kruskal-
Wallis test, followed by Dunn's post-test, when comparing more than 
two variables. Statistical significance was considered when P < 0.05.
3  | RESULTS
3.1 | Malaria does not affect visceral yolk sac 
histomorphological parameters
The wall of the visceral yolk sac in both PBA-infected and control an-
imals exhibited its three typical layers: an outer (uterine-facing) en-
dodermic epithelium, a blood vessel-enriched mesodermal mid-layer 
and an inner (amnion facing) mesothelial layer. There were no visible 
differences in gross morphology of these layers between infected 
and control groups (Figure 1A,B). Additionally, MiP did not affect the 
volumes of the histological components of the yolk sac, comparing 
PBA-infected and control groups (Figure 1A). Of note, constitutive 
endodermic epithelium comprised approximately 66% of the total 
Gene Sequence (5′-3′) Encoded Protein Reference
Abca1 F:GCAGATCAAGCATCCCAACT
R:CCAGAGAATGTTTCATTGTCCA
ABCA1 Hirai et al, 2007
Abcb1a F:CTCTATTGGACAAGTGCTCACTG
R:CTCCTCGTGCATTGGCGAA
P-glycoprotein (P-gp) Hirai et al, 2007
Abcb1b F:AAGCCAGTATTCTGCCAAGCAT
R:CTCCAGACTGCTGTTGCTGATG








Merrell et al, 2014
Snat1 F:GGACGGAGATAAAGGCACTC
R:CAGAGGGATGCTGATCAAGG
SNAT1 Jones et al, 2014
Snat2 F:ACCTTTGGTGATCAAGGCAT
R:AGGACCAGATAGTCACCGTT






GLUT1 Feil et al, 2006
Ccl2 F:AGGTCCCTGTCATGCTTCTG
R:ATCTGGACCCATTCCTTCTTG
C-C Motif Chemokine 
Ligand 2 (CCL2)
Zammit et al, 2013
IL-6 F:GAGGATACCACTCCCAACAGACC
R:AAGTGCATCATCGTTGTTCATACA














Chemokine Ligand 1 
(CXCL1)











aGene-specific primers were designed with primer-BLAST (http://www.ncbi.nlm.gov/tools/ prime 
r-blast). 
TA B L E  1   Primers used for qPCR
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yolk sac cell number, whereas the constitutive mesothelium formed 
approximately 5% of the total number of yolk sac cells (Figure 1C).
3.2 | Malaria modifies expression of ABC efflux 
transporters and pro-inflammatory factors in the 
yolk sac
mRNA of all ABC transporters evaluated (Abca1, Abcb1a, Abcb1b, Abcg1 
and Abcg2) was detected in the mouse visceral yolk sac at term (GD18.5) 
in both control and PBA-infected experimental groups. Abcb1a mRNA 
was up-regulated, whereas Abcg1 was down-regulated in the yolk 
sac of infected animals, compared to controls (P < 0.05; Figure 2). No 
changes in Abca1, Abcb1b and Abcg2 were observed. Analysis of other 
active transmembrane (intake) transporters in the yolk sac revealed 
that Snat1 and Snat2 mRNA levels were unaffected by MiP; Snat4 and 
Glut1 transcripts were undetectable in both experimental groups. At 
the level of the pro-inflammatory genes, we detected increased lev-
els of the macrophage migration inhibitory factor (the Mif chemokine) 
mRNA, while interleukin (Il)-1β and C-C Motif chemokine ligand 2 (Ccl2) 
F I G U R E  1   Malaria in pregnancy 
(MiP) does not affect visceral yolk sac 
morphology and morphometry. A-B, yolk 
sac photomicrographs (HE) of (A) control 
and (B) Plasmodium berghei ANKA (PBA)-
infected dams. C, Volumetric proportion 
of the yolk sac histological components 
from control and PBA-infected dams 
at GD18.5. Arrowheads = endodermic 
epithelium; thin arrows = mesothelium; 
* = mesodermic blood vessels. Statistical 
differences were tested by Kruskal-Wallis 
test, followed by Dun's post-test. Data are 
presented as mean ± SEM (n = 6/group). 
Magnification bars represent 50 µm. 1% 
of structures found were classified as 
artefacts
F I G U R E  2   Malaria in pregnancy (MiP) modifies the yolk sac gene expression of specific ABC efflux transporters and pro-inflammatory 
factors. Relative mRNA expression of selected ABC (Abca1, Abcb1a, Abcb1b, Abcg1 and Abcg2) and nutrient (Snat1 and Snat2) transporters, 
as well as selected cytokines and chemokines (Il-1β, Ccl2 and Mif) in the yolk sac from Plasmodium berghei ANKA-infected dams at GD18.5. 
Transcripts of Il-6, Cxcl1, Glut1 and Snat4 were under detectible limits. Statistical differences were tested by Mann-Whitney test. *P < 0.05. 
Data are presented as mean ± SEM (n = 6/group)
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mRNA remained unchanged. Transcripts of Il-6 and chemokine (C-X-C 
motif) ligand 1 (Cxcl1, a human Il-8 analog) were not detectable in the 
yolk sac (Figure 2).
3.3 | Malaria in pregnancy modifies P-gp and Abca1 
protein in the yolk sac
We next evaluated the effects of PBA infection on protein localization 
and expression (semi-quantitative) of the ABC transporter that exhib-
ited altered gene expression following infection. P-gp was enriched 
in the apical membrane and cytoplasm of the outer endodermic epi-
thelium and inner mesothelial cells. The endothelium of blood vessels, 
localized in the mesodermal mid-layer, exhibited faint or no P-gp label-
ling, whereas the mesodermal layer connective tissue was completely 
negative for P-gp (Figure 3A,B). In PBA-infected pregnancies, distribu-
tion of yolk sac P-gp was similar to controls; however, semi-quantita-
tive analysis revealed increased P-gp protein in the plasma membranes 
of the endodermic epithelium and mesothelium (P < 0.05), with no 
changes in the total area of P-gp immunolabelling (Figure 3F,G).
ABCG1 protein was detected in both the endodermic epithelium 
and the endothelium of mesodermal vessels of the yolk sac, with 
lower levels of ABCG1 detected in the mesothelium. No ABCG1 was 
detected in the mesodermal layer connective tissue (Figure 4A,B). 
There were no differences in ABCG1 immunostaining area and in-
tensity between PBA-infected and control pregnancies (Figure 4F,G).
F I G U R E  3   P-glycoprotein (P-gp) is 
localized in distinct cellular barriers of 
the murine yolk sac and is up-regulated 
by malaria in pregnancy (MiP). A-E, 
Representative immunohistochemistry 
(IHC) images from murine yolk 
sac sections of control (A) and (B) 
Plasmodium berghei ANKA-infected 
dams at GD18.5. C-D: yolk sac (C) 
and placental (D) negative controls. 
E, Placental positive control showing 
P-gp immunoreactivity in labyrinthine 
and junctional zone cells. F-G: Semi-
quantitative evaluation of the area (F) 
and intensity (G) of P-gp immunolabelling. 
Arrowheads = endodermic epithelium; 
thin arrows = mesothelium; * = 
mesodermal blood vessels. Statistical 
differences were tested by Mann-Whitney 
test. *P < 0.05. Data are presented as 
mean ± SEM (n = 6/group). Magnification 
bars represent 100 µm
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A disconnect between mRNA and protein expression patterns 
for some ABC transporters has been previously reported in the pla-
centa.16,35 As such, we conducted immunohistochemical analysis 
of ABCA1 lipid and BCRP drug transporters in the mouse yolk sac. 
ABCA1 was primarily localized to the endodermic epithelium, with 
heterogeneous intensity. In addition, the cytoplasm of some epithe-
lial cells was positive for ABCA1. The mesothelium and the endothe-
lium of mesodermal vessels were also stained, but with less intensity 
compared to the endodermic epithelium (Figure 5A,B). No ABCA1 
staining was observed in the connective tissue. Semi-quantitative 
analysis showed that both area and intensity of ABCA1 staining 
were increased in the endothelium of the mesodermal blood vessels 
(P < 0.05) in MiP, with no changes in the endodermic epithelium or in 
the mesothelium (Figure 5F,G).
BCRP staining was localized to the endodermic epithelium and 
in the endothelium of mesodermal vessels, with lower levels in 
the mesothelium regions of the yolk sac. Semi-quantitative analy-
sis revealed no effect of MiP on BCRP in any regions of the yolk 
sac (Figure 6A,B). As predicted, mouse placentae-positive con-
trols exhibited intense ABCA1, ABCG1, BCRP and P-gp staining in 
F I G U R E  4   ABCG1 immunolocalization 
in the murine yolk sac. A-E, 
Representative immunohistochemistry 
(IHC) images from murine yolk 
sac sections of control (A) and (B) 
Plasmodium berghei ANKA-infected 
dams at GD18.5. C-D: yolk sac (C) 
and placental (D) negative controls. 
(E) Placental positive control showing 
ABCG1 immunoreactivity in labyrinthine 
and junctional zone cells. F-G: Semi-
quantitative evaluation of the area (F) and 
intensity (G) of ABCG1 immunolabelling. 
Arrowheads = endodermic epithelium; 
thin arrows = mesothelium; * = 
mesodermal blood vessels. Statistical 
differences were tested by Mann-Whitney 
test. Data are presented as mean ± SEM 
(n = 6/group). Magnification bars 
represent 100 µm
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labyrinthine and in junctional zone cells (Figures 3-6E), whereas neg-
ative controls showed minimal signal (Figures 3-6C,D).
4  | DISCUSSION
Our study provides new insights into how the yolk sac exerts embryo 
and foetal protection. We have also demonstrated how MiP impacts 
the expression of transporters that modulate yolk sac permeability 
to drugs, environmental toxins and nutrients. Using a mouse model 
of malaria-induced IUGR and PTL, we detected increased expression 
of P-gp/Abcb1a and Mif chemokine in the yolk sac, and endothelial 
ABCA1 staining in blood vessels. In contrast, we demonstrated a de-
crease in yolk sac Abcg1 mRNA levels in MiP.
Previously, we have demonstrated that MiP impairs the placental 
expression of ABCA1/Abca1, P-gp/Abcb1b and BCRP/Abcg2, which 
were accompanied by increased placental levels of Cxcl1 and Ccl2 
mRNA and up-regulation of maternal Il1-β, Il-6, Cxcl1 and Ccl2.9 In 
the previous study, we provided evidence that MiP has the poten-
tial to increase foetal exposure to drugs and environmental toxins, 
F I G U R E  5   ABCA1 staining is 
increased in the endothelium of the 
mesodermal blood vessels in malaria-
infected dams. A-E, Representative 
immunohistochemistry (IHC) images 
from murine yolk sac sections of control 
(A) and (B) Plasmodium berghei ANKA-
infected dams at GD18.5. C-D: yolk sac 
(C) and placental (D) negative controls. 
(E) Placental positive control showing 
ABCA1 immunoreactivity in labyrinthine 
and junctional zone cells. F-G: Semi-
quantitative evaluation of the area (F) and 
intensity (G) of ABCA1 immunolabelling. 
Arrowheads = endodermic epithelium; 
thin arrows = mesothelium; * = 
mesodermal blood vessels. Statistical 
differences were tested by Mann-Whitney 
test. *P < 0.05. Data are presented as 
mean ± SEM (n = 6/group). Magnification 
bars represent 100 µm
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via down-regulation of major placental drug and nutrient ABC efflux 
transporters.9 Moreover, other studies have demonstrated the sensi-
tivity of placental P-gp and BCRP to infection. C57BL/6 mice exposed 
to sublethal (foetal) LPS in mid-pregnancy, exhibited impaired pla-
cental P-gp activity,18 while polyinosinic:polycytidylic acid (PolyI:C, 
a viral mimic) had no effect on placental P-gp activity.36 Human 
first-trimester placentae exposed to lipopolysaccharide (LPS, a bac-
terial antigen) exhibited decreased P-gp/ABCB1 and BCRP/ABCG2 
levels.37 In contrast, human chorioamnionitis in 2nd trimester, often 
resulting from polymicrobial infection,38 resulted in decreased P-gp 
levels but elevated BCRP expression.16 Further, extravillous tropho-
blast (HTR8/SVneo)-like cells treated with LPS and single-stranded 
RNA (ssRNA, another viral mimic) showed a profound down-regula-
tion of BCRP/ABCG2.14 Together, these studies demonstrate that the 
nature of the infective stimuli determines the type of the drug efflux 
transporter response in different trophoblast lineages.
Notably, in the present study, we did not observe substantial 
up-regulation of pro-inflammatory factors in the yolk sac following 
F I G U R E  6   BCRP immunolocalization in 
the murine yolk sac. A-E, Representative 
immunohistochemistry (IHC) images 
from murine yolk sac sections of control 
(A) and (B) Plasmodium berghei ANKA-
infected dams at GD18.5. C-D: yolk sac 
(C) and placental (D) negative controls. 
(E) Placental positive control showing 
BCRP immunoreactivity in labyrinthine 
and junctional zone cells. F-G: Semi-
quantitative evaluation of the area (F) and 
intensity (G) of BCRP immunolabelling. 
Arrowheads = endodermic epithelium; 
thin arrows = mesothelium; * = 
mesodermal blood vessels. Statistical 
differences were tested by Mann-Whitney 
test. Data are presented as mean ± SEM 
(n = 6/group). Magnification bars 
represent 100 µm
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MiP. Out of the five pro-inflammatory genes investigated, Mif chemo-
kine was up-regulated, Il-1β and Ccl2 were unchanged and Il-6 and 
Cxcl1 were not detectible. In this context, the MIF chemokine is 
present at high levels in the amniotic fluid of women in PTL with in-
fection and its expression is increased in chorioamniotic membranes 
during infection.39
The pattern of the pro-inflammatory response observed in the 
yolk sac is in contrast with our previous report showing placental 
up-regulation of Cxcl1 and Ccl2, induced by MiP.9 Together, these 
results suggest that the yolk sac mounts a blunted pro-inflamma-
tory response to systemic malarial infection when compared to the 
placenta. The placenta would appear to be efficient in buffering the 
transfer of malarial antigens and related pro-inflammatory cyto-
kines/chemokines to the yolk sac and to the embryo/foetus. This 
may explain, at least in part, the different ABC transporter response 
pattern in the yolk sac, compared to the placenta.
In rodents, P-gp is encoded by two different gene isoforms, 
Abcb1a and Abcb1b. Yolk sac Abcb1a was the gene isoform up-regu-
lated by MiP and was associated with increased P-gp immunostain-
ing in both the uterine-facing membrane of endodermic cells and in 
the inner, amnion side-facing, mesothelial cells. While MiP did not 
alter the morphology of the yolk sac wall, the changes in P-gp and 
ABCA1 likely alter the barrier function of the yolk sac. However, our 
morphometric analysis detected a higher number of constitutive 
outer endodermic cells (≈66%) in comparison with inner mesothelial 
cells (≈5%), in the control and MiP groups. This higher number of 
constitutive endodermic cells in the yolk sac, in concert with in-
creased cell membrane P-gp, suggests that MiP leads to a greater 
net outflow of P-gp substrates from the foetal side, towards the 
uterine cavity (endoderm-mediated), rather than into the foetal side 
(mesothelium-mediated), likely favouring foetal protection.
Apart from drugs and environmental toxins, P-gp also transports 
pro-inflammatory compounds, Il-2, INF-γ, TNF-α and CCL2. As such, 
it can play an important role in the regulation of local inflammatory 
response.40,41 Up-regulation of yolk sac P-gp in PBA-infected dams 
indicates this membrane has the potential to act together with other 
gestational tissues, such as the placenta, to participate in the im-
munomodulatory response to MiP. It is currently unknown whether 
this represents a compensatory mechanism to circumvent decreased 
placental P-gp and BCRP expression induced by MiP, or if this is an 
inherent response to MiP infection. This clearly requires further 
investigation.
Despite reduced yolk sac Abcg1, no changes in ABCG1 stain-
ing were observed. In contrast, increased ABCA1 levels were de-
tected only in yolk sac endothelial cells of PBA-infected pregnancies. 
ABCA1 and ABCG1 are important cholesterol transporters, located 
on both the plasma and endosomal cell membranes.42 In gestational 
tissues, apart from being localized in human syncytiotrophoblasts, 
ABCA1 and ABCG1 are also present in foetal endothelial cells of the 
placenta, acting in the exchange of cholesterol and phospholipids in 
the maternal interface.12,43 Importantly, ABCA1 can also be localized 
in intracellular compartments such as the endoplasmic reticulum, 
functioning as regulator of intracellular signalling, cell differentiation 
and hormone metabolism.44 Changes in the expression of cholesterol 
transporters may adversely impact pregnancy outcome. Inhibition 
of ABCG1 and ABCA1 expression by siRNA transfection increased 
the sensitivity of human trophoblast cells to cytotoxic 25-hydroxy-
cholesterol and 7-ketocholesterol oxysteroids, resulting from pla-
cental oxidative stress. On the other hand, induction of ABCA1 and 
ABCG1 in the trophoblast conferred placental protection against 
these agents,43 demonstrating an important role of these lipid ef-
flux transporters protecting trophoblast cells against cytotoxic lipid 
derivates. Furthermore, disruption of ABCA1 and ABCG1 may be 
harmful to the establishment of pregnancy and placentation, since 
they regulate hormone synthesis and nutrient transport in the pla-
centa.45 Increased vascular ABCA1 may be the result of the yolk 
sac attempting to maintain normal cholesterol homoeostasis in the 
foetal compartment, given that cholesterol is an essential element 
for the development and survival of the central nervous and other 
foetal organ systems.16,46
In addition, we did not identify changes in gene expression of 
neutral amino acid transporters (Snat1 and Snat2) or of Snat4 and 
Glut1 glucose transporters in the yolk sac in MiP. Such data suggest 
that gene expression of neutral amino acid and glucose transporters, 
at least in term pregnancies, is less impacted by malarial infection.
In conclusion, we have shown, for the first time, that yolk sac 
efflux transport potential may be disrupted by MiP. The presence of 
ABC transporters in the yolk sac wall and their selective alterations 
induced by MiP suggest that this foetal membrane acts as an import-
ant protective gestational barrier under normal conditions as well 
as in malaria disease. Changes in the expression pattern of yolk sac 
ABCA1 and P-gp may alter the biodistribution of toxic substances, 
xenobiotics, nutrients and immunological factors within the foetal 
compartment and therefore participate in the pathogenesis of ma-
laria-induced IUGR and PTL. In addition, based on our data, it is pos-
sible to hypothesize that MiP, along with other infective processes, 
has the potential to disrupt the human yolk sac protective barrier 
and thus impact early pregnancy outcome. This highlights the im-
portance of investigating the human yolk sac response to infection.
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